Table 3. Phase-II studies on Larazotide. A recent meta-analysis of RCTs on larazotide acetate including 626 CeD patients who underwent ingestion of gluten ranging from 2.5 grams for 3 days up to 2.7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback